+
Site Tour

EuroPCR 2023: Improving outcomes in mitral regurgitation

Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.

Related Videos

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Tricuspid valve

EuroPCR 2023: Vascular access

EuroPCR 2023: Defining the future

Navitor™ Voice of the Experts Lars Sondergaard

Navitor™: Animation

SAFETY IS A JOURNEY | X. Freixa & F. Castriota

TAVI Summit - TAVR in bicuspid

TAVI Summit 2023: AS with HF

Safety with TriClip TEER

AV VALVES 2023: MR – Mixed MR

TriClip™ G4: Animation

TRENDING TOPICS

HFA Tutorials 2025 I.Stankovic

HFA Tutorials 2025
STRAIN and echo workshop | How to assess an HF patient

HFA Tutorial 2025 E.Donal | Case based

HFA Tutorials 2025
Case based | How to manage a Secondary AV valve disease, with a focus on Tricuspid

HFA Tutorials 2025 E.Donal

HFA Tutorials 2025
Simulation & Hands-on | How to treat an HF patient with the TEER therapy

CONNEXT


HUB
RELATED RESOURCES

ACC 2023: COAPT™ trial

PCR LV 2021: Navitor™ Looking ahead

Navitor Valve in small aortic annuli

Poster: Primary MR in the Very Elderly

CONNEXT


LIVE
RELATED EVENTS

Case Transmission | Tricuspid focus

TAVI Summit - Cardiac imaging

AV VALVES 2023:HF and VHD – Patient Management

TAVI Summit - TAVR in bicuspid

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline